3rd Quarter - Report

ILLUMINA, INC. for ILLUMINA, INC.

Period 3rd Quarter 2026 Filed Oct 20, 2026 Signed by Jason D. Kaune, Attorney & Agent for Filer

Official filing
Firm
ILLUMINA, INC.
Client
ILLUMINA, INC.
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions related to biotechnology innovations

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Homeland Security HOM

Discussions related to U.S. government disease surveillance programs

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: State, Dept of (DOS); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

H.R. 7118: Genomic Answers for Childrens Health Act of 2026; all provisions

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7118 (119th)

Trade (domestic/foreign) TRD

General issues related to trade

LobbyistCovered position, as disclosed
JENIFER HEALY —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Treasury, Dept of; Executive Office of the President (EOP); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.